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Introduction: Amyloidosis most often manifests as a systemic involvement of multiple tissues and organs, and
an amyloidal deposit confined to the stomach is extremely rare. It is sometimes difficult to provide a definitive
diagnosis of localized gastric amyloidosis by biopsy specimen and diagnosis of amyloidosis in some cases has
been finalized only after surgical resection of the stomach.
Case presentation: A 76-year-old Japanese woman with epigastric discomfort underwent an
esophagogastroduodenoscopy procedure. The esophagogastroduodenoscopy revealed gastric wall thickening,
suggesting scirrhous gastric carcinoma, at the greater curvature from the upper to the lower part of the gastric
corpus. A biopsy specimen revealed amyloid deposits in the submucosal layer with no malignant findings. We
resected a representative portion of the lesion by endoscopic mucosal resection using the strip biopsy method
to obtain sufficient tissue specimens, and then conducted a detailed histological evaluation of the samples.
The resected specimens revealed deposition of amyloidal materials in the gastric mucosa and submucosa without
any malignant findings. Congo red staining results were positive for amyloidal protein and exhibited green
birefringence under polarized light. Congo red staining with prior potassium permanganate incubation confirmed
the light chain (AL) amyloid protein type. Based on these results, gastric malignancy, systemic amyloidosis and
amyloid deposits induced by inflammatory disease were excluded and this lesion was consequently diagnosed as
localized gastric amyloidosis. Our patient was an older woman and there were no findings relative to an increase
in gastrointestinal symptoms or anemia, so no further treatment was performed. She continued to be in good
condition without any finding of disease progression six years after verification of our diagnosis.
Conclusions: We report an unusual case of primary amyloidosis of the stomach resembling scirrhous gastric
carcinoma. This case of localized gastric amyloidosis was differentiated from scirrhous gastric cancer after
performing endoscopic mucosal resection without an invasive surgical resection, as endoscopic mucosal resection
provided sufficient tissue specimens from the lesion to make an accurate histological evaluation.
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Figure 1 Barium upper gastrointestinal X-ray series findings. Barium upper gastrointestinal X-ray series indicating rigidity and poor
extensibility of the gastric wall from the upper to lower gastric body.
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The term amyloidosis refers to a group of disorders
characterized by extracellular accumulation of insoluble,
fibrillar proteins in various organs and tissues. Amyloid-
osis most often manifests as systemic involvement of
multiple tissues and organs, and an amyloidal deposit
confined to the stomach has been extremely rare in
previously published reports. It is sometimes difficult to
provide a definitive diagnosis of localized gastric amyl-
oidosis by biopsy specimen and diagnosis of amyloidosis
in some cases was definitively made only after surgical
resection of the stomach.
Case presentation
A 76-year-old Japanese woman presented to our facility
with epigastric discomfort; she had previously undergone
an esophagogastroduodenoscopy (EGD) procedure at
another hospital. The EGD had revealed gastric wall
thickening, suggesting scirrhous gastric carcinoma, so
our patient was referred to our hospital for further
examination and treatment.Figure 2 Esophagogastroduodenoscopy findings. Esophagogastroduod
at the greater curvature from the upper to lower part of the gastric corpusA barium upper gastrointestinal X-ray series indicated
rigidity and poor extensibility of the gastric wall from the
fornix to the lower gastric body, and irregular, enlarged
folds were also noticeable (Figure 1). EGD revealed red-
dish and markedly swollen folds at the greater curvature
from the upper to the lower part of the gastric corpus
(Figure 2). The mucosa surface was hemorrhagic and
erosive. A biopsy specimen revealed amyloid deposits in
the submucosal layer with no malignant findings. Endo-
scopic ultrasound showed obvious thickening of the third
layer corresponding to the submucosal layer with no dis-
ruption of the gastric wall structure (Figure 3). Com-
puted tomography (CT) revealed thickening of the
gastric wall and enlarged circumambient lymph nodes.
Biopsy specimens from the rectum and ileum indicated
no amyloid deposition. Laboratory test results were
negative for Bence-Jones protein in the urine, and serum
immunoglobulin levels were normal. No abnormal signs
were detected on echocardiography.
We resected a representative portion of the lesion by
endoscopic mucosal resection (EMR) using the stripenoscopy revealing reddish and markedly swollen folds with erosions
.
Figure 3 Endoscopic ultrasound findings. Endoscopic ultrasound
showing obvious thickening of the submucosal layer without
disruption of the gastric wall structure.
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we then conducted a detailed histological evaluation
(Figure 4). There were no complications associated with
the EMR. The resected specimens revealed deposition
of amyloidal materials in the gastric mucosa and sub-
mucosa with no malignant findings. Congo red staining
results were positive for amyloidal protein and exhibited
green birefringence under polarized light microscopy.
Congo red staining with prior potassium permangan-
ate incubation confirmed the light chain (AL) amyloid
protein type. An immunohistochemical examination
revealed that κ-chain-positive plasma cells were present
only in the inflammatory infiltrate in the superficial
lamina propria, while λ-chain-producing plasma cells
were detected both in the mucosa and in the underlying
lymphomatous proliferation (Figures 5, 6, 7). Based onFigure 4 Macroscopic findings from endoscopic mucosal resection (E
endoscopic mucosal resection was performed using the strip biopsy methothese results, gastric malignancy, systemic amyloidosis
and amyloid deposits induced by inflammatory disease
were excluded and the lesion was consequently diag-
nosed as localized gastric amyloidosis. Our patient was
an older woman and there were no findings relative to
an increase in gastrointestinal symptoms or anemia, so
no further treatment was performed and she continued
to be in good condition with no findings of disease pro-
gression six years after verification of our diagnosis.
Discussion
The term amyloidosis refers to a group of disorders
characterized by extracellular accumulation of insoluble,
fibrillar proteins in various organs and tissues [1]. It can
result from a heterogeneous group of disorders and
cause impairment or even dysfunction of involved organs
[2]. Various subtypes exist, including primary systemic
amyloidosis, reactive systemic amyloidosis associated
with a chronic inflammatory condition and localized
forms of aberrant amyloid deposition [3]. Amyloidosis
most often manifests as systemic involvement of multiple
tissues and organs including the heart, liver, spleen,
kidneys, lymph nodes, adrenals and thyroid in addition
to many others. The clinical implication of a single organ
or tissue is relatively unusual and reports of an amyloidal
deposit confined to the stomach are extremely rare in
the previously published literature [2,3].
Clinical symptoms of localized gastric amyloidosis are
often uncharacteristic and varied, including epigastric
discomfort, poor appetite, hematemesis, hematochezia
and gastric perforation [2,3]. In addition, the gross
appearance of localized gastric amyloidosis also takes
various forms such as redness, erosion, ulcer, polypoid
mass, thickened folds and scirrhous-like morphology [4].
Its polypoid-mass or scirrhous-like appearance usually
tends to be misdiagnosed as a gastric tumor such as gas-
tric cancer or malignant lymphoma due to similarities
in gastrointestinal symptoms and gross appearance asMR) specimens. Resection of representative portions of lesion by
d.
Hematoxylin and Eosin Stain
Congo Red Stain Congo Red Stain with Prior
Potassium Permanganate Incubation 
Figure 5 Pathology results. The resected specimen revealed positive deposition of light chain type amyloidal proteins from both Congo red
staining and Congo red staining with prior potassium permanganate incubation.
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nostic modalities, such as a CT scan. In this respect, it
has been suggested that biopsy is the only reliable means
to confirm diagnosis [1,5] although it is not always pos-
sible to provide a definitive diagnosis from a biopsy spe-
cimen, and the diagnosis of amyloidosis has been
finalized in some cases only after surgical resection of
the stomach [6]. In particular, there have been no pub-
lished case reports describing scirrhous-like localized
gastric amyloidosis diagnosed by biopsy specimen that
were subsequently only followed up with no surgical
intervention. Therefore, the present case is the first
report of scirrhous-like localized gastric amyloidosis diag-
nosed by a different approach than surgery. The literature
review of cases of localized gastric amyloidosis is shown
in Table 1.Congo Red Stain
P
Figure 6 Polarized microscopy. Polarized microscopy showing green bireWith regard to diagnosis of scirrhous type gastric can-
cer, histological confirmation using biopsy specimens is
also sometimes difficult; accuracy of pre-operative histo-
logical diagnosis of scirrhous type gastric cancer has ran-
ged from 58% to 70% in previously published reports
[13,14]. In the present case, therefore, the possibility
of scirrhous type gastric cancer could not be excluded
because of the similarity in gross appearance despite
a biopsy specimen indicating amyloid deposits with no
malignant findings. Strip biopsy was developed as an
EMR technique for early gastric cancer in 1984 [15] and
makes it possible to obtain a larger resected specimen
compared to a biopsy specimen that enables more pre-
cise histological diagnosis. It was particularly important
in this case that scirrhous-like localized gastric amyloidosis
could be diagnosed by evaluating such precise histologicalCongo Red  Stain with Prior  
otassium Permanganate Incubation
fringence of deposits.
Figure 7 Immunohistochemical investigation. (a) κ-Chain-positive plasma cells present only in inflammatory infiltrate in the superficial lamina
propria. (b) λ-Chain-producing plasma cells detected both in the mucosa and underlying lymphomatous proliferation.
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the existence of scirrhous type gastric cancer by only
using EMR without the necessity of performing an inva-
sive surgical resection.
Primary amyloidosis refers to the disorder in patients
with no preceding or co-existing disease except immu-
nocyte dyscrasis in which the extracellular substance is
composed of AL protein produced by plasma cells, as
typically seen in multiple myeloma. The major forms of
systemic amyloidosis also include reactive systemic
amyloidosis consisting of a non-immunoglobulin protein
secreted by the liver in the setting of chronic inflamma-
tory disorders or cancers [3]. Localized gastric amyloid-
osis is characterized by AL type amyloid deposition in
the mucosal or submucosal layer of the gastric wall
[3,16]. In our patient’s case, deposition of AL type amyl-
oid in the stomach was revealed by detailed histological
examination of the EMR specimens, including Congo
red staining with prior potassium permanganate incu-
bation. The diagnosis of localized gastric amyloidosis
was then confirmed after ruling out systemic amyloid
involvement in other organs. Obtaining sufficient tissue
specimens from representative changes in our patient’sTable 1 Review of the literature on cases of localized gastric
Age/sex Chief issue Localization Form Amyloi
protein
55/M Epigastric pain Lower body Mucosal redness Unknow
69/F Left flank pain Antrum Mucosal redness AL
58/M Appetite loss Lower body Depression AA
50/F Epigastric
discomfort
Lower body Ulcer AA
63/M None Antrum Ulcer, tumor AL
67/M Appetite loss Cardia Tumor AL
51/F None Middle body
to antrum
Scirrhous type AL
68/F Pain, nausea Antrum Scirrhous type Unknow





Scirrhous type ALlesion using EMR, therefore, made it possible to initially
perform a detailed histological evaluation including dif-
ferential staining of elastic fibers and subsequently con-
firm the localized deposition of AL type amyloid in the
stomach. In addition, we were also able to exclude gas-
tric malignancies such as gastric cancer and malignant
lymphoma by evaluating those same specimens, so EMR
could well become an important diagnostic method for
determining localized gastric amyloidosis.
Currently, there are no published reports that mention
in particular any specific therapy for localized gastric
amyloidosis. Some reports have documented that sur-
gical resection with lymph node dissection may be a
preferable therapeutic strategy to prevent possible com-
plications such as bleeding and obstruction [2,6]. In con-
trast, no further treatment is deemed to be necessary in
other reports if the patient is symptom free on clinical
follow-up. In addition, several reports indicate periodic
controls should be scheduled to follow evolution of
the disease and facilitate early recognition of multi-
organ involvement [3,7]. We did not perform any treat-
ment in this case and there were no subsequent findings
of disease progression, but an evaluation involving aamyloidosis
d Operation Prognosis Author, year and
reference
n − Survival Rotondano et al., 2007 [7]
− Died (Other disorder) Yoshida et al., 1998 [8]
− Survival Ishii et al., 1993 [9]
+ Survival Wu et al., 2003 [2]
+ Survival (18 months) Nishida et al., 1990 [10]
− Survival Deniz et al., 2006 [3]
+ Survival (two months) Kato et al., 1988 [11]
n + Died (10 months) Ikeda et al., 1988 [12]
n + Survival Nfoussi et al., 2010 [4]
− Survival (six years) Present case, 2012
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future to determine the proper management of localized
gastric amyloidosis.
Conclusions
In summary, this rare case of localized gastric amyloid-
osis was differentiated from scirrhous gastric cancer
without performing invasive surgical resection as the
use of EMR provided sufficient tissue specimens from
the lesion to make an accurate diagnosis of localized
deposition of AL type amyloid with no malignant find-
ings possible.
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